Are you at #AATS2024 ? Stop by our booth #905 and the surgical suite at #105 for an unparalleled hands-on learning experience using simulation models, featuring Hybrid AF™ Therapy for LSPAF patients, LAA exclusion and Cryo Nerve Block for post-op pain management.
#CardioTwitter

Breaking news! New data presented during #AATS2024 by Dr. Patrick McCarthy concluded surgical LAA exclusion during open cardiac surgery in patients without Afib was associated with 4 years of ischemic stroke and mortality benefit. See the full abstract: okt.to/l6piA5

Stop by our booth tomorrow at #AATS2024 to meet with our team of experts to discuss the importance and value of LAAE, now a Class 1A recommendation, and how Hybrid AF™ Therapy can benefit your LSPAF patients. Plus, get hands-on with our simulation model. 
#CardioTwitter #Epeeps

Congratulations to Barts Heart Centre, St George's University Hospital, and Bristol Heart Institute for pioneering the first UK cases with EPi-Sense ST™! EPi-Sense ST offers a new approach to ablation procedures, allowing surgeons to fine-tune their technique using deflection…

EPi-Sense ST™ is now MDR approved and available across Europe for the treatment of Advanced Afib patients! The first European cases recently took place at Rigshospitalet IM MONTSOURIS Asklepios Kliniken Deutsches Herzzentrum der Charité and C. C. Monzino.

Learn more about EPi-Sense ST:…

Interested in learning the impact of surgical LAA exclusion in non-Afib patients from a real-world data set? Join Dr. Patrick McCarthy at #AATS24 on Sunday, April 28, for the Presidential Recognition abstract.
#Cardiotwitter #LAAE #MedEd

Discover Cryo Nerve Block at #AATS2024 ! Join us Saturday, 7 p.m., to explore its role in post-op pain management for thoracic procedures. Learn about its mechanism, patient referrals, and expectations, plus engage in a round table on professional experiences. Secure your spot:…

Cardiothoracic surgeon Dr. Drotar and EP Dr. Atteya from Cooperman Barnabas Medical Center joined forces to treat their first LSPAF patient with Hybrid AF™ Therapy.

Together, they exemplify a dual approach yielding better outcomes. Discover the innovative strategy reshaping LSPAF treatment:…

With features like dynamic closing force, tissue compression, & epicardial exclusion, AtriClip® devices are the most widely implanted LAAM devices worldwide.
Learn more about the benefits of #LAAE by stopping by booth #905 at AATS or visit: okt.to/Cbfcp3
#CardioTwitter

The CEASE-AF randomized controlled trial demonstrated long-term durability of Hybrid ablation through 24 months of follow-up and ~33% absolute improvement in freedom from atrial arrhythmias* in patients with LSPAF.**​
​
Learn more: bit.ly/3xth6Qi​
​
*Freedom from atrial…

Crafted with retractable handles and flexible tube sets, cryoICE® offers ergonomic capabilities, adapting seamlessly to various hand positions for enhanced maneuverability.

Discover the power of cryoICE at: okt.to/x9QVUj
#Cardiotwitter

For heart valve or coronary artery bypass surgery, when a concomitant ablation is needed, the EnCompass™ Clamp can access the posterior wall of the left atrium.

Add an ablation without doing an atriotomy. 

Learn more about at: okt.to/Dtcimh

Introducing, cryoSPHERE®+ probe. With more than 60,000 patients treated with Cryo Nerve Block, we're proud to provide surgeons with a new insulation technology. Read more at: bit.ly/3JmsDnh #cryoNB

“Trying to decrease nerve pain by using Cryo Nerve Block is wonderful for patients” – Trisha Wilcox, NP. 

Learn why HCPs are choosing cryoNB and providing patients with up to three months of post-op pain management at:  okt.to/hvDKqI 
#cryoNB #PatientsFirst

Dr. Waxman and the BayCare team are bringing relief to VATS lung resection patients with Cryo Nerve Block. With dedication and expertise, Dr. Waxman and his team have reached a milestone, treating 100 patients with cryoNB over the past three years!
Learn more about #cryoNB :…

Join us at #HRS2024 to discover the potential of Hybrid AF™ Therapy! With proven results like 98% or greater Afib burden reduction at 12 months, it's revolutionizing LSPAF treatment.

See the data behind Hybrid AF Therapy at: okt.to/Thcrol #Afib #Epeeps #Cardiac